Alcon Inc.
Healthcare · USD · XETRA
Price
$52.065
Cap
$30.51B
Earnings
—
30d Trend
-12.5%
32% annualised over 90 days
BRAIN47 SIGNAL
Raw weighted: 54×Macro 0.99 (−1%)=53
RISK
QUALITY
MOMENTUM
TECHNICAL
FUNDAMENTALS
Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%
BRAIN47 HORIZON ANALYSIS
Long-term compounder with 3.1% yield
BRAIN47'S ASSESSMENT
I rate Alcon Inc. at 53/100 — a MODERATE reading on the Brain47 Signal. The strongest factor is quality at 66/100. I classify this as a income position with the strongest thesis on a long-term horizon.
PAST PERFORMANCE
1 MONTH
-10.3%
3 MONTHS
-22.3%
12 MONTHS
—
Trailing returns — past performance, not a projection.
DETAILED ANALYSIS
Long-term compounder with 3.1% yield. Quality (66) and Fundamentals (62) are the primary strengths. I note that momentum is the weakest area at 42/100 — this warrants monitoring. Historical volatility is moderate at 32%. I classify this as an income position — the 3.1% yield combined with the dividend profile makes it suitable for income generation.
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.
